JP2019509985A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509985A5
JP2019509985A5 JP2018539955A JP2018539955A JP2019509985A5 JP 2019509985 A5 JP2019509985 A5 JP 2019509985A5 JP 2018539955 A JP2018539955 A JP 2018539955A JP 2018539955 A JP2018539955 A JP 2018539955A JP 2019509985 A5 JP2019509985 A5 JP 2019509985A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
item
use according
electronic monitoring
monitoring device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018539955A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/016018 external-priority patent/WO2017136421A1/en
Publication of JP2019509985A publication Critical patent/JP2019509985A/ja
Publication of JP2019509985A5 publication Critical patent/JP2019509985A5/ja
Priority to JP2022129292A priority Critical patent/JP2022172151A/ja
Pending legal-status Critical Current

Links

JP2018539955A 2016-02-01 2017-02-01 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ Pending JP2019509985A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022129292A JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662289473P 2016-02-01 2016-02-01
US62/289,473 2016-02-01
PCT/US2017/016018 WO2017136421A1 (en) 2016-02-01 2017-02-01 Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022129292A Division JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Publications (2)

Publication Number Publication Date
JP2019509985A JP2019509985A (ja) 2019-04-11
JP2019509985A5 true JP2019509985A5 (https=) 2020-03-12

Family

ID=58462619

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018539955A Pending JP2019509985A (ja) 2016-02-01 2017-02-01 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ
JP2022129292A Pending JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022129292A Pending JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Country Status (13)

Country Link
US (2) US10010294B2 (https=)
EP (1) EP3411030A4 (https=)
JP (2) JP2019509985A (https=)
KR (1) KR20180102201A (https=)
CN (2) CN114847965A (https=)
AU (1) AU2017215189A1 (https=)
CA (1) CA3012333A1 (https=)
GB (2) GB2581301A (https=)
IL (1) IL260335B2 (https=)
MX (1) MX2018009248A (https=)
RU (1) RU2768748C2 (https=)
SG (2) SG10202012584UA (https=)
WO (1) WO2017136421A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114847965A (zh) 2016-02-01 2022-08-05 英凯达治疗公司 电子监测联合吸入药理学疗法管理心律失常
CA3060702A1 (en) 2017-05-10 2018-11-15 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
ES3040411T3 (en) 2018-03-22 2025-10-30 Incarda Therapeutics Inc A novel method to slow ventricular rate
WO2019236694A1 (en) * 2018-06-05 2019-12-12 Incarda Therapeutics, Inc. Methods for diagnosing brugada syndrome using an aerosol
WO2020109761A1 (en) * 2018-11-27 2020-06-04 Ipsen Biopharm Limited Dosing calculator for spasticity
KR102891439B1 (ko) * 2019-08-01 2025-11-25 인카다 테라퓨틱스, 인크. 항부정맥 제제
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
AU2021400335A1 (en) 2020-12-17 2023-06-22 Incarda Therapeutics, Inc. Kits and methods for induction of cardioversion in subjects with atrial arrhythmias
CN116867483A (zh) * 2020-12-17 2023-10-10 英凯达治疗公司 用于诱导患有房性心律失常的对象的心脏复律的试剂盒和方法
KR102932737B1 (ko) * 2020-12-22 2026-03-04 필립모리스 프로덕츠 에스.에이. 습도 센서 및 가습기를 갖춘 에어로졸 발생 장치
WO2025217305A1 (en) * 2024-04-10 2025-10-16 Incarda Therapeutics, Inc. Devices, kits, and methods for delivering medication via the lungs

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1004593A (en) 1911-03-25 1911-10-03 Catherine Ryan Measuring device for cutting garments.
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
SE408265B (sv) 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
US4247066A (en) 1978-02-21 1981-01-27 General Dynamics Corporation Airfoil variable cambering device and method
IT1116047B (it) 1979-04-27 1986-02-10 Sigma Tau Ind Farmaceuti Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
US4930518A (en) * 1988-09-26 1990-06-05 Hrushesky William J M Sinus arrhythmia monitor
US4962095A (en) 1989-02-15 1990-10-09 E. R. Squibb & Sons, Inc. Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
WO1993000951A1 (en) 1991-07-02 1993-01-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
NZ281112A (en) 1994-03-07 1998-04-27 Inhale Therapeutic Syst Powdered insulin delivered as an aerosol
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
ES2245780T3 (es) 1994-05-18 2006-01-16 Nektar Therapeutics Metodos y composiciones para la formulacion de interferones como un polvo seco.
JP3388896B2 (ja) 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
ES2237767T3 (es) 1995-04-14 2005-08-01 Nektar Therapeutics Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada.
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6077543A (en) 1996-12-31 2000-06-20 Inhale Therapeutic Systems Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
WO1999016420A1 (en) 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in nebulizers
US20020017295A1 (en) 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
CN1169520C (zh) 1997-09-29 2004-10-06 耐科塔医药公司 多孔微粒及其使用方法
US6541479B1 (en) 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
US7308894B2 (en) * 1998-06-03 2007-12-18 Scott Laboratories, Inc. Apparatuses and methods for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures according to appropriate clinical heuristics
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
DE19835346A1 (de) 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
DE69935154T2 (de) 1998-11-12 2007-10-25 Inc. Transave Inhalationssystem
EP1181069B1 (en) 1999-05-28 2006-06-28 Nektar Therapeutics Apparatus and method for aerosolising a powder pharmaceutical composition
US8002700B2 (en) * 1999-12-30 2011-08-23 Medtronic, Inc. Communications system for an implantable medical device and a delivery device
DE60128902T2 (de) 2000-04-17 2008-02-14 Vectura Ltd., Chippenham Formulierungen zur verwendung in inhalationsvorrichtungen
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
US6357490B1 (en) 2000-08-22 2002-03-19 Advanced Inhalation Research, Inc. System, method and apparatus for filling containers
SE517229C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Kontinuerlig inhalator för torrt pulver
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
JP4119751B2 (ja) * 2000-11-28 2008-07-16 メドトロニック・インコーポレーテッド 埋め込み可能な医療装置
CA2432319A1 (en) 2000-12-21 2002-07-18 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
WO2002080859A2 (en) 2001-03-20 2002-10-17 Glaxo Group Limited Inhalation drug combinations
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20080038363A1 (en) 2001-05-24 2008-02-14 Zaffaroni Alejandro C Aerosol delivery system and uses thereof
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
JP4795637B2 (ja) 2001-09-28 2011-10-19 カーブ テクノロジー,インコーポレイティド 鼻ネブライザー
US6968226B2 (en) * 2002-01-30 2005-11-22 Medtronic, Inc. Method and system for terminating an atrial arrhythmia
ATE418991T1 (de) 2002-04-18 2009-01-15 Cv Therapeutics Inc Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker
EP1356762A1 (de) * 2002-04-22 2003-10-29 UbiCom Gesellschaft für Telekommunikation mbH Geräteanordnung zur Fernüberwachung von Körperfunktionen
US7607436B2 (en) 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US8245708B2 (en) 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
EP1515768B1 (en) 2002-05-07 2013-11-06 The State University of New York at Stony Brook Devices for targeted endobronchial therapy
US6871089B2 (en) * 2002-06-05 2005-03-22 Card Guard Technologies, Inc. Portable ECG monitor and method for atrial fibrillation detection
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
RU38570U1 (ru) 2002-12-19 2004-07-10 Главный военный клинический госпиталь им. акад. Н.Н. Бурденко Комплекс лечения нарушений сердечного ритма
TR200502522T2 (tr) 2002-12-31 2005-09-21 Nektar Therapeutics Çözünmez bir aktif madde içeren farmasötik formülasyon
MXPA05011428A (es) 2003-04-24 2006-05-31 Aderis Pharmaceuticals Inc Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
US7967756B2 (en) 2003-09-18 2011-06-28 Cardiac Pacemakers, Inc. Respiratory therapy control based on cardiac cycle
US20050142070A1 (en) * 2003-09-18 2005-06-30 Hartley Jesse W. Methods and systems for assessing pulmonary disease with drug therapy control
US20070118054A1 (en) * 2005-11-01 2007-05-24 Earlysense Ltd. Methods and systems for monitoring patients for clinical episodes
US8403865B2 (en) * 2004-02-05 2013-03-26 Earlysense Ltd. Prediction and monitoring of clinical episodes
WO2005079897A1 (en) * 2004-02-25 2005-09-01 Resmed Limited Cardiac monitoring and therapy using a device for providing pressure treatment of sleep disordered breathing
CA2464029A1 (en) 2004-04-08 2005-10-08 Valery Telfort Non-invasive ventilation monitor
CN101001633A (zh) 2004-05-21 2007-07-18 特兰萨夫公司 肺病和肺病前期病症的治疗
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20060120962A1 (en) 2004-10-12 2006-06-08 Rabinowitz Joshua D Cardiac safe, rapid medication delivery
TWI396541B (zh) 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
JP4931930B2 (ja) 2005-10-21 2012-05-16 メルク・シャープ・エンド・ドーム・コーポレイション カリウムチャネル阻害剤
ITMI20051999A1 (it) 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
EP2069009A1 (en) * 2006-09-28 2009-06-17 Medtronic, Inc. Implantable medical device with sensor self-test feature
RU2463085C2 (ru) 2006-10-25 2012-10-10 Новартис Аг Аппарат для распыления порошка, способ его изготовления и применения и его компоненты
EP2099295A4 (en) 2006-11-22 2010-02-24 Reliant Pharmaceuticals Inc PROPHYLAXIS AND TREATMENT OF AURICULAR FIBRILLATION WITH OMEGA-3 FATTY ACIDS
TW200840578A (en) 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
US20080275036A1 (en) 2007-05-02 2008-11-06 Apt Pharmaceuticals, Inc. Prevention and treatment of cardiac conditions
WO2008134630A1 (en) 2007-04-30 2008-11-06 Apt Pharmaceuticals Dexrazoxane compounds for cardioprotection
US9320448B2 (en) * 2008-04-18 2016-04-26 Pacesetter, Inc. Systems and methods for improved atrial fibrillation (AF) monitoring
US20110144125A1 (en) 2008-08-14 2011-06-16 The Uab Research Foundation Anti-Arrhythmia Agents, Methods of Their Use, Methods of Their Identification and Kits Therefore
US8501727B2 (en) 2008-08-22 2013-08-06 Milestone Pharmaceuticals Inc. Short acting benzothiazepine calcium channel blockers and uses thereof
CA2778604C (en) 2008-09-23 2021-10-05 Laboratory Skin Care, Inc. Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
US20100112081A1 (en) 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
AU2013248242B2 (en) * 2009-03-18 2016-08-18 Incarda Therapeutics, Inc Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
CA2835771C (en) 2009-03-18 2017-01-24 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
WO2012024106A2 (en) * 2010-08-17 2012-02-23 University Of Florida Research Foundation, Inc. Central site photoplethysmography, medication administration, and safety
ITRM20110390A1 (it) 2011-07-21 2013-01-22 Eramo Alessandra D Prodotto per stimolare la produzione endogena di mediatori dell'infiammazione.
KR102169734B1 (ko) * 2012-11-28 2020-10-26 이-니코틴 테크놀로지, 인크. 화합물 전달을 위한 방법 및 장치
CA2946253C (en) * 2013-05-06 2022-08-09 University Health Network Methods of administering dantrolene for the acute treatment of cardiac arrhythmias
GB2522727B (en) * 2013-11-26 2017-01-25 Purity Health Pharma Ltd Pulmonary delivery devices
CN114847965A (zh) 2016-02-01 2022-08-05 英凯达治疗公司 电子监测联合吸入药理学疗法管理心律失常
CA3060702A1 (en) 2017-05-10 2018-11-15 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration

Similar Documents

Publication Publication Date Title
JP2019509985A5 (https=)
RU2018131232A (ru) Сочетание электронного мониторинга с ингаляционной фармакологической терапией для контроля сердечных аритмий, включая мерцательную аритмию
JP6696772B2 (ja) 非侵襲性の換気を提供するためのシステム及びフェイス・マスク
JP2011529083A5 (https=)
JP2018070616A (ja) 高濃度の一酸化窒素の投与法
JP2014514271A5 (https=)
Lee et al. Torsades de pointes after ondansetron infusion in 2 patients
Mohideen et al. Basics of Management of Medical Emergencies in Dental Offi ce and Emergency Drug Kit
JP2016510040A5 (https=)
Derr et al. Emergency & Critical Care Pocket Guide
RU2010120806A (ru) Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид
Chrystyn et al. P154 Evaluation of Inhaler Technique Mastery for Budesonide Formoterol Spiromax® Compared with Symbicort Turbohaler® in Adult Patients with Asthma: Primary Results From the Easy Low Instruction Over Time [ELIOT] Study
Meek et al. Medicines for COPD
RU2626768C2 (ru) Способ лечения бронхиальной астмы
RU2018144594A (ru) Способ лечения синдрома дыхательной недостаточности у больных острым ишемическим инсультом
Garkhede et al. ASTHMA DISEASE AND IT'S TREATMENT COMPETITIVE OID PUMP VS NEW PUMP
Grant1 et al. Mining emergencies
Wigen-Dewey Manual Resuscitation Self-Inflating Bag-Valve-Mask Device
Bruene Respiratory Distress-football: 581 May 28 120 PM-140 PM
Katipoğlu et al. Acute Management of Spinal Cord Injury at the Out-of-Hospital and Emergency Department Settings
Yagi How the RECOVER guidelines changed Veterinary CPR.
Dresler MS15. 02 Pharmacotherapy Supports Cessation
Kocaoglu Pulmonary haemosiderosis and other toxicities following intoxication: case report
Verdu Solans Hydralazine overdose
CN106692743A (zh) 一种三臣混悬液及其制备方法